API

ROSUVASTATIN CALCIUM

Drug classification

Dosage form

TABLET;ORAL

API strength per dosage

EQ 5MG BASE

Dose

Mechanism of action

Indications

Primary hyperlipidemia, mixed dyslipidemia, hypertriglyceridemia, primary dysbetalipoproteinemia, homozygous familial hypercholesterolemia, heterozygous familial hypercholesterolemia, prevention of cardiovascular disease.

Side effects

Myalgia, increased liver enzymes, headache, nausea, abdominal pain, constipation, asthenia, diabetes mellitus, rhabdomyolysis, memory loss, confusion, immune-mediated necrotizing myopathy.

Pregnancy category

Category X.

Precautions

Contraindications